Prescription drug · ANDA
Nifedipine NDC 71610-689
Nifedipine 30 mg/1 · Tablet, Extended release · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-689-30 | 71610068930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-689-30)Marketed from Feb 1, 2023 | |
| 71610-689-53 | 71610068953 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-689-53)Marketed from Feb 1, 2023 | |
| 71610-689-60 | 71610068960 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-689-60)Marketed from Feb 1, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nifedipine
- Generic name (nonproprietary)
- nifedipine
- Active ingredients
- Nifedipine — 30 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202987
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 71610-689_57e2138d-9144-44c7-926e-73810d632cecSPL ID 57e2138d-9144-44c7-926e-73810d632cecSPL set ID 75bb3a1f-3cb7-4450-8e59-27521a1ebc25RxCUI 198034UNII I9ZF7L6G2L
- Pharmacologic class
- Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610068930followed by a unit qualifier and the quantityPackage 71610-0689-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Nifedipine extended-release tablets, USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202987
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-624 |
| Nifedipine | Nifedipine 30 mg/1 | Tablet, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-622 |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-623 |
| Nifedipine | Nifedipine 30 mg/1 | Tablet, Extended releaseOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-841 |
| Nifedipine | Nifedipine 30 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-620 |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-621 |
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | Ingenus Pharmaceuticals, LLC | 50742-622 |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | Northwind Health Company, LLC | 51655-780 |